CysDB: a human cysteine database based on experimental quantitative chemoproteomics
Cell Chemical Biology, ISSN: 2451-9456, Vol: 30, Issue: 6, Page: 683-698.e3
2023
- 38Citations
- 87Captures
- 1Mentions
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations38
- Citation Indexes38
- 38
- CrossRef27
- Captures87
- Readers87
- 87
- Mentions1
- News Mentions1
- News1
Most Recent News
Reports Outline Life Sciences Study Results from University of California Los Angeles (UCLA) (Cysdb: a Human Cysteine Database Based On Experimental Quantitative Chemoproteomics)
2023 JUL 27 (NewsRx) -- By a News Reporter-Staff News Editor at Chemicals & Chemistry Daily Daily -- A new study on Life Sciences is
Article Description
Cysteine chemoproteomics provides proteome-wide portraits of the ligandability or potential “druggability” for thousands of cysteine residues. Consequently, these studies are facilitating resources for closing the druggability gap, namely, achieving pharmacological manipulation of ∼96% of the human proteome that remains untargeted by U.S. Food and Drug Administration (FDA) approved small molecules. Recent interactive datasets have enabled users to interface more readily with cysteine chemoproteomics datasets. However, these resources remain limited to single studies and therefore do not provide a mechanism to perform cross-study analyses. Here we report CysDB as a curated community-wide repository of human cysteine chemoproteomics data derived from nine high-coverage studies. CysDB is publicly available at https://backuslab.shinyapps.io/cysdb/ and features measures of identification for 62,888 cysteines (24% of the cysteinome), as well as annotations of functionality, druggability, disease relevance, genetic variation, and structural features. Most importantly, we have designed CysDB to incorporate new datasets to further support the continued growth of the druggable cysteinome.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S2451945623000909; http://dx.doi.org/10.1016/j.chembiol.2023.04.004; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85162019024&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/37119813; https://linkinghub.elsevier.com/retrieve/pii/S2451945623000909; https://dx.doi.org/10.1016/j.chembiol.2023.04.004
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know